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ABSTRACT  
Purpose: A rapidly evolving resuscitation science provides more effective treatments 
to an aging population with multiple comorbidites. Concurrently, emergency care has 
become patient-centered. This review aims to describe challenges associated with the 
application of key principles of bioethics in resuscitation and post-resuscitation care; 
propose actions to address these challenges; and highlight the need for evidence-based 
ethics and consensus on ethical principles’ interpretation. 
Methods: Following agreement on the article’s outline, subgroups of 2-3 authors 
provided narrative reviews of ethical issues concerning autonomy and honesty, 
beneficence/nonmaleficence and dignity, justice, specific practices/circumstances 
such as family presence during resuscitation, and emergency research. Proposals for 
addressing ethical challenges were also offered.   
Results: Respect for patient autonomy can be realized through honest provision of 
information, shared decision-making, and advance directives/care planning. Essential 
prerequisites comprise public and specific healthcare professionals’ education, 
appropriate regulatory provisions, and allocation of adequate resources. Regarding 
beneficence/nonmaleficence, resuscitation should benefit patients, while avoiding 
harm from futile interventions; pertinent practice should be based on neurological 
prognostication and patient/family-reported outcomes. Regarding dignity, aggressive 
life-sustaining treatments against patients’ preferences should be avoided. Contrary to 
the principle of justice, resuscitation quality may be affected by race/income status, 
age, ethnicity, comorbidity, and location (urban versus rural or country-
specific/region-specific). Current evidence supports family presence during 
resuscitation. Regarding emergency research, autonomy should be respected without 
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hindering scientific progress; furthermore, transparency of research conduct should be 
promoted and funding increased.     
Conclusions: Major ethical challenges in resuscitation science need to be addressed 
through complex/resource-demanding interventions. Such actions require support by 
ongoing/future research. 
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INTRODUCTION 
    Ongoing changes in medicine, and the societal context in which it is practised, 
create a range of ethical challenges for clinicians. Rapid progress in resuscitation 
science and intensive care provides increased opportunities to treat patients [1,2], 
while an aging population and increased prevalence of people with multiple 
comorbidities raises questions about how much benefit these treatments can bring. 
Concurrently, there has been a move from paternalistic to patient-centered care with a 
more informed population and an increasing focus on individual rights and values. 
Key ethical documents and guidelines have both reflected and contributed to this 
change [2-6] and there is a substantial literature on the application of key ethical 
principles in resuscitation medicine [1,3-15; see also the electronic supplementary 
material (ESM)].         
    Evidence-based standards of emergency care and related ethical considerations 
should evolve simultaneously to ensure high-quality care [1,5]. However, the 
interpretation of ethical principles in the context of resuscitation/end of life decision-
making may vary among different countries and cultures for various reasons 
[1,5,16,17].  
    The objectives of the current narrative review are to 1) describe current and 
emerging challenges associated with the application of ethical principles in 
resuscitation and subsequent critical care; a brief, pertinent summary is presented in 
Table 1; 2) propose possible ways, actions, and initiatives to address these challenges; 
and 3) highlight the need for research evidence-based ethics and international 
consensus [17] on the perception of ethical principles in relation to resuscitation.  
 
 
We have defined the relevant ethical principles as follows:  
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 Autonomy: respect for the right of self-determination [1,7] 
 Honesty: accurate and transparent communication to the patient/family of the 
best research evidence, and clinical judgment including uncertainties.   
 Beneficence: selection of beneficial interventions for the patient after 
assessment of the risk-to-benefit ratio [1,3] 
 Non-maleficence: avoiding harm or inflicting the least possible harm in the 
course of achieving a beneficial outcome [1].  
 Dignity: comprises "being human," "having control," "relationship and 
belonging", and "maintaining the individual self" [1,18]; regarding 
resuscitation and postresuscitation care, dignity means avoiding 
disproportional interventions and an "end-of-life" contradicting patient’s 
preferences. 
 Justice: means fair and equal distribution of benefits, risks, and costs; pertains 
to the equality of rights to healthcare, and the legal obligation of healthcare 
providers to adhere to appropriate care and allocation of burdens and benefits 
[1].  
REPECTING PATIENT PREFERENCES 
Means to safeguard the autonomy of incapacitated cardiac arrest patients include 
advance directives, advance care planning (ACP), and consulting their trusted/loved 
ones to establish previously expressed wishes. Advance directives and ACP 
frequently concern an individual’s preferences regarding cardiopulmonary 
resuscitation (CPR) and other life-sustaining treatments (LSTs) [19].  
Advance directives   
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    Advance directives address cases of patients with loss of decisional capacity and 
include living wills (instruction directives) and appointment of a "health care proxy" 
with durable power of attorney to make healthcare decisions (proxy directive) 
[1,10,19,20]. Instruction directives may comprise summary/general or 
detailed/specific descriptions of the patient’s values, goals, and preferences regarding 
healthcare issues and interventions [1,11,19,20]. Specific preferences may include do-
not-attempt CPR (DNACPR). 
    Healthy individuals drafting living wills may attempt to cover a broad spectrum of 
diseases, without having the required "medical knowledge and a grasp of the resulting 
conditions" [21]. This may result in ambiguity of the directive, challenging its 
applicability, and necessitating interpretation under specific clinical conditions [20]. 
Advance directives’ legal status depends on cultural, religious, sociolinguistic, 
political, and medico-ethical factors [22], and varies widely among European 
countries from "not mentioned in law" to "legally binding" [6,20].   
    Living wills drafted during health may not reflect changing preferences due to 
aging, occurrence of serious illness, and/or cognitive decline [23-25]; such factors 
may also affect the physicians’ preferences about their own healthcare [25]. However, 
>70% of elderly inpatients with previously stated resuscitation preferences may 
ultimately wish their family and physician decide for them [26].  Conversely, recent 
evidence suggests that advance directives may promote comfort care and prevent end-
of-life overtreatment [27]; this is consistent with nonmaleficence and dignity.  
ACP  
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    Advance directives and ACP exhibit major differences. ACP focuses on shared 
decision-making between clinician and patient. It is a dynamic, iterative process of 
eliciting and recording informed preferences of patients about end-of-life care, and 
accordingly pre-specifying and prioritizing future treatment goals. This is achieved 
through communication among patients, trained healthcare professionals, family, and 
other loved ones [28]. ACP may help the patient cope with death, and alleviate ethical 
burden from and strengthen relationships with his/her loved ones [29].  
    Recent evidence on complex and resource-demanding interventions (see ESM) 
suggests that ACP promotes congruency of care with patients’ wishes and associated 
patient and/or family satisfaction; reduces family stress, anxiety and depression; and 
may reduce the overall rates of ˚aggressive˚ LSTs [28], which accords with 
nonmaleficence and dignity. The effective linking of patients’ wishes to realizable 
care plans requires multifaceted approaches {eg, the Physicians Orders for LSTs 
(POLST) forms / registry [30]} and a specific healthcare policy of enacting supportive 
regulations and making recorded patients’ preferences and goals easily accessible to 
emergency caregivers [31].  
    Integration of DNACPR preferences with ACP - which includes patient preferences 
about outcomes and/or other treatments (besides resuscitation) - has been advocated 
to help address major issues currently associated with "isolated" DNACPR orders [8]. 
Such problems include lack of participation of patient/family in decision-making [8], 
inappropriate CPR [3,4,6,8] or CPR resulting in poor, patient-perceived quality of life 
[1], and withholding of other indicated treatments such as pain relief and fluid intake 
[8]. Withholding of indicated treatments is related to misinterpretation of DNACPR 
and is not ethically justified [32]. 
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Consent for interventions and shared decision-making 
    Article 5 of the Biomedicine Convention states that "An intervention in the health 
field may ONLY be carried out AFTER the person concerned has given free and 
informed consent to it" [33]. Consent validity may depend on 1) an individual’s 
ability to understand essential information about their illness and indicated treatment, 
appraise the gravity of their condition, compare risks and benefits, and express a 
rational choice [10]; 2) availability of adequate time to decide [14]; and 3) concurrent 
emotional stress [15]. In emergency situations such as cardiac arrest, and in the 
absence of any readily accessible, CPR-specific, recorded patient preferences and/or 
DNACPR orders, immediate necessity dictates a "treat first, discuss later" approach 
(Tables 1 and 2).   
    In challenging cases of ongoing, postresuscitation patient incapacity and absence of 
any associated, advance directives or ACP, decisions on LSTs should reflect the result 
of a collaborative process enabling shared-decision making of surrogates and 
clinicians after considering the available evidence [34] and the patient’s values goals 
and preferences [10,35]. Other challenges may include accuracy of surrogates’ 
estimates of patient preferences [36], potential subjectivity of physicians’ predictions 
for post-discharge, health-related quality of life (QoL) [37], and possible 
disagreements/conflicts between surrogates of equivalent standing and/or between 
surrogates and clinicians [38]; in the absence of recorded, informed DNACPR 
preferences, physician-issued DNACPR orders based on poor prognosis may 
occasionally contradict surrogates’ overoptimistic expectations from aggressive LSTs 
[1,6]. Conflicts -if not timely resolved (eg, with the aid of an Ethics Committee)- may 
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lead to indecisiveness regarding indicated treatment(s) and poor patient outcomes 
[38]. 
PRESENTING INFORMATION FOR DECISION MAKING 
        An essential prerequisite for autonomy is the informed and meaningful 
patient/family involvement in decision-making. In the context of honesty, the 
physician should: 
a. Present all options and likely outcomes in a clear and comprehensible manner 
[7]. Failure to thoroughly discuss with surrogates comfort care alternatives to 
aggressive care may lead to therapeutic decisions that do not accord with 
patient preferences [39]. 
b. Discuss the relation between resuscitation intervention-associated burden and 
benefit, preferably by using individualized choice architecture; this includes a 
hierarchical presentation of treatment options starting from the most 
appropriate according to physician judgment [40]. 
c. Actively engage in religious/spiritual discussions as pertinent end-of-life 
concerns may substantially affect surrogates’ decisions; a multicenter, 
prospective, cohort study suggested that intensive care professionals 
frequently fail to address such concerns [41]. 
d. Ensure that the patient/family is given sufficient time to consider options, 
weigh up risks and benefits, and consult with others [42]. 
    Models for predicting survival from attempted CPR have been developed and 
internally validated using large, in-hospital registry data sets [34]. However, the 
communication of statistical estimates of risk for poor outcome to patients/families 
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may prove challenging, depending on their ability to comprehend the message, their 
beliefs about their individual risk relative to the general population, and the elicitation 
of emotional reaction(s) [43]. Furthermore, even if probabilistic outcomes could be 
accurately conveyed, the reality of a prolonged recovery period in a neurologically 
deficient state may be difficult to predict [44]. Uncertainties about the potential 
severity and duration of disability should be disclosed.  
    Physicians may feel torn between the desire to present a "full picture" – including 
that of limited resources - in order to meet stringent criteria for respecting patient 
autonomy, and the desire to protect patients from anxiety and burdensome decision-
making while they are already unwell; occasionally, doctors may exercise a 
"therapeutic privilege" and withhold some information [45] about a resuscitation 
decision.   
BENEFITING WITHOUT HARMING 
    Since medical interventions are potentially harmful, physicians should ensure that 
the balance favors benefit. The ethical challenge arises because of uncertainty about 
potential benefit and harm that might occur in an individual case. This is increased in 
situations where patients cannot communicate and their views on potential benefits 
and harms of interventions are unknown.  In the context of CPR, these ethically 
difficult decisions occur when considering initiating CPR, terminating CPR and 
limiting LSTs following return of spontaneous circulation (ROSC). 
    There is a potential risk of harm during/after CPR. Data from 27 European 
countries suggest that among patients resuscitated from out-of-hospital cardiac arrest 
(OHCA), 75% (individual, country-reported range, 50-90%) do not achieve ROSC 
before hospital admission; and the overall, in-hospital/30-day mortality rate amounts 
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to 90% (country-reported range, 69-99%) [46]. Similar mortality data have been 
reported for the United States and Canada (year 2010, in-hospital mortality, 90%; 
region-specific range, 81-94%)  [47] and Australia (year 2015, in-hospital/30-day 
mortality, 88%; region-specific range, 83-91%) [48]. In OHCA survivors to hospital 
discharge, hypoxic-ischemic brain injury (HIBI) frequently results in long-term 
cerebral disability, including persistent vegetative state [49]. Among Australian 
patients aged ≥65 years, the estimated proportion of moderate-to-severe neurological 
disability or death at 12 months postarrest amounted to 44% [50]. Predicting when 
CPR is unlikely to result in a neurologically meaningful survival and knowing in 
advance the patient values and preferences is crucial to prevent harmful resuscitation 
efforts. This is difficult to achieve, especially in OHCA which is more unpredictable, 
with little available information about the patient’s clinical status or personal wishes. 
The default is therefore to start CPR immediately in all OHCAs, unless obvious signs 
of irreversible death are present or when there is a valid advance directive or a 
DNACPR order [Table 2; 3,4,6].  The ethical default is to preserve life and defer 
assessments of best interests until relevant information is available.  
    Conversely, for in-hospital cardiac arrest (IHCA), most events are witnessed and/or 
monitored and life support from healthcare personnel is immediately available. 
DNACPR may be in place in those in whom attempted CPR would probably be 
unsuccessful (Table 2; see ESM) In a recent survey, DNACPR orders were used in 
22/32 European countries (69%) [5].  IHCA differs from OHCA in terms of patients’ 
prearrest, acute/chronic comorbidities, prearrest therapeutic interventions, cardiac 
arrest-precipitating cause, and prognosis (Table 2). In the United States, the 2009 risk-
adjusted, in-hospital mortality was 78%; among survivors, the proportions of 
clinically significant and severe disability were 28% and 10%, respectively [51]; risk-
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adjusted, in-hospital mortality varies widely among hospitals, ie, from 68% to 100% 
[52]. 
    If initial resuscitative efforts are unsuccessful the original assessment of pertinent 
benefits and harms should be reviewed. The European Resuscitation Council’s 
(ERC’s) ethical guidelines suggest that healthcare professionals should consider 
terminating resuscitation efforts in cases of asystole for >20 minutes despite ongoing 
advanced life support, in the absence of a reversible cause [3]. In general, survival 
with good neurological outcome is unlikely when OHCA duration exceeds 30 minutes 
[3]. However, this rule is not universal (see ESM) and it has been recently challenged 
by the advent of extracorporeal CPR [53]. Regarding IHCA, clinical decision aids 
have been proposed [34; see above and ESM]; however, a large-scale external 
validation of the associated clinical scoring system is still pending.   
    Assessment of HIBI severity can guide the ethically difficult decision of whether 
and when to avoid disproportionate care for these patients. In 2014, guidelines for 
neurological prognostication after cardiac arrest were co-issued by the ERC and the 
European Society of Intensive Care Medicine [54]. These guidelines are based on a 
multimodal approach combining clinical examination and relevant investigations to 
predict poor neurological outcome with the greatest possible accuracy in patients who 
are comatose with absent or extensor motor response to pain at ≥3 days after ROSC.  
However, the quality of evidence supporting these predictors is low or very low and 
when prognosis appears to be indeterminate, or indicators give contradictory results, 
prolonged LST may be indicated. 
        Another limitation of neurological prognostication indices is the inconsistency in 
definitions of what represents a poor neurological outcome [55]: the QoL reported by 
cardiac arrest survivors or their caregivers is generally lower than that described by 
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traditional outcome measures [56]. When assessing the appropriateness of 
resuscitative interventions, prognostication aids should be based on patient-reported 
and/or family-reported rather than clinician-reported outcomes. Cardiac arrest studies 
should include QoL measures and assess patient/family-reported outcomes [57,58].  
OPTIMIZING END-OF-LIFE TREATMENT 
    Successful implementation of ACP with support by the next-of-kin and attending 
physicians should result in efficacious, end-of-life comfort-care.    
    In postresuscitation care, LST is often withdrawn based on shared decision-making 
[9,10], and/or when the likelihood of neurologically favourable survival is extremely 
low [34], and clinical evidence indicates "disproportionate use" [59]. The distinction 
between allowing a patient to die after LST withdrawal and deliberate termination of 
life remains unanswered. Many doctors believe that a ventilator-dependent patient is 
allowed to die after LST withdrawal due to the underlying patient’s condition or 
severe organ failure. Others regard LST withdrawal as the immediate cause of death 
as most patients die within the next 30 minutes [60]. Varying viewpoints on LST 
withdrawal may reflect cultural/religious influences [22]. Distressing symptoms 
should be anticipated and alleviated by sedatives and opioids; these agents do not 
seem to shorten the dying process [61]. Current European Guidelines are consistent 
with palliative sedo-analgesia to reduce patient awareness of pain and suffering, 
without hastening death [10]. 
EQUAL ACCESS TO BEST-QUALITY CARE 
    Cardiac arrest patients should be provided with the same, timely, and high-quality 
resuscitation and postresuscitation care. Contrasting this ideal, a ten-fold, 
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intercontinental variation in reported OHCA incidence and outcomes (eg, overall 
survival to hospital discharge from approximately 1% to 10%) has been previously 
documented [62].  
    As detailed above, OHCA outcomes vary greatly among European countries; this 
may be attributable to between-country differences in emergency care organization 
and quality, and availability and allocation of resources [5,46]. In North America,  
substantial, regional differences in OHCA in-hospital mortality may be partly 
explained by variable bystander CPR rates, and differences in the quality of 
postresuscitation care among hospitals [47,63; see ESM].          
    In Europe, emergency care quality seems to be affected by patient comorbidity and 
age, and location (eg, urban or rural) and type (eg, teaching, tertiary care) of admitting 
and/or treating hospital [5; Table 3]. Urban versus rural location (eg, in Japan; see 
ESM) can impact the available workforce, quality and frequency of provider training, 
volume of emergency care resources, and response time (due to geographic 
dispersion, distance, and ambulance availability). In the United States, the 
combination of low income and black race seems to negatively impact bystander CPR 
rates [64]; these findings cannot be generalized to other racial or ethnic groups, given 
the scarcity of relevant studies. Collectively, these challenges represent inequalities in 
access, treatment, and outcome. 
    Access to specific hospital resources (eg, targeted temperature management, post-
ROSC cardiac catheterization, extracorporeal CPR) are labor-intensive, expensive, 
and require specialized personnel with wide variation in availability. Even among 
high-resource countries with wide implementation of extracorporeal CPR, this 
resource is expectedly concentrated in urban tertiary hospitals with availability of 
advanced cardiovascular care (see ESM). Out-of-hospital use of extracorporeal CPR 
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is even less common and generally restricted to Emergency Medical Services systems 
staffed by physicians with mobile intensive care unit capability [65]. 
    Focusing on improvement and consistent provider training, bystander CPR, 
availability and use of automated external defibrillators, and more standardized 
resuscitation practices would improve the justice of resuscitation. Modifying system-
level factors likely require a central champion, dedicated funding, and organizations 
that are receptive and malleable to change. There is evidence that improvement in 
survival from cardiac arrest can improve over time with heightened focus on system 
factors, feedback, quality of CPR, tracking outcomes, and training [47].   
    Rationing in resuscitation presents challenges regarding the objectivity and ethical 
integrity of criteria applied for DNACPR/LST decisions [66]. Utilitarian allocation of 
limited resources can be based on futility and/or differences in prognosis/LST cost 
[66,67]. Futility has been defined as "the use of considerable resources without a 
reasonable hope that the patient would recover to a state of relative independence or 
be interactive with their environment" [66]. However, without quantification of 
"considerable", "reasonable", "relative independence", and "interactive", beneficial 
treatment can be arbitrarily/unethically denied to vulnerable population subgroups 
such as the elderly, the disabled, or those with chronic or hereditary or genetic 
diseases/anomalies [66].  
        Table 3 displays OHCA versus IHCA differences concerning justice. 
SPECIFIC CLINICAL PRACTICES OR CIRCUMSTANCES  
    These include family presence during resuscitation, pediatric/neonatal resuscitation, 
slow code, provider safety, organ donation, and end-of-life treatments for "very 
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recent" (ie, ≤2 years) immigrants/refugees. Ethical challenges are summarized in 
Table 4 and detailed in the ESM.  
ETHICAL ISSUES IN EMERGENCY RESEARCH  
    In cardiac arrest research, respect for autonomy is challenging, because the 
immediate necessity for resuscitation precludes obtaining pre-enrollment, informed 
consent [13,14]. For low-risk research [13], ethically/publicly acceptable, alternative 
consent models include deferred consent, and exception to informed consent (EFIC) 
with prior community consultation [13,68]. In deferred consent, the patient or his/her 
next-of-kin or legally authorized representative are informed about the study as soon 
as possible and informed consent for continued participation is requested; this consent 
model can be applied in emergency research involving incapacitated patients in the 
European Union [13]. If the patient dies before the next-of-kin can be reached, 
practices may vary based on weighing transparency and informing the relatives 
against the associated burden/harm. In EFIC, information is shared with the relevant 
communities and community members are provided with the opportunity to opt out by 
requesting "NO STUDY" [69]; this consent model can be used in emergency research 
in the United States [13; ESM]. Table 5 displays the characteristics of these consent 
models and associated ethical challenges, including the issue of consent validity 
[1,13-15]. Additional consent models such as integrated consent and prospective 
consent have been detailed elsewhere [1]. Once enrolled in a trial, withdrawal of 
consent may introduce bias, as those doing less well are more likely to withdraw [70]. 
Some authorities (eg, United States Food and Drug Administration) but not all (eg, 
European Union authorities) forbid participants from withdrawing data that have 
already been collected up to the time that they rescind their consent.  Additional 
challenges are detailed in the ESM. 
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Commercial and noncommercial academic research 
    Efforts to address issues of flawed study design, selective reporting, "ghostwriting", 
and "guest" or "gift" authorship (see ESM) have included compulsory, pre-enrollment 
registration of trial protocols, posting of results to trial registries, and journal 
publication within 12 and 24 months of trial completion (respectively), and a call for 
disclosure of results from still-unreported trials [71]. Furthermore, journals oblige 
authors to detail the sponsor’s role and their own contributions as regards study 
conception, design, and conduct, data analysis and interpretation, and manuscript 
preparation and approval for submission.  
    Another major issue concerns prioritization of research according to public health 
need. Despite recently confirmed steady improvements, cardiac arrest outcomes still 
remain dismal [46-48,50-52,72]. Considering the pertinent public health mortality 
burden, cardiac arrest resuscitation guidelines are based on 35 to 53 times lesser 
randomized clinical trials per 10000 deaths per year as compared with guidelines for 
myocardial infarction, heart failure, and stroke [72]. Research on high-cost, patent 
protected drugs or devices has received disproportionately higher industry and/or 
governmental funding relative to much-needed, non-commercial, academic 
resuscitation research on patent-unprotected, low-cost, widely used drugs of still-
uncertain efficacy, such as epinephrine, or antiarrhythmics [72].  
 
ADDRESSING MAJOR CHALLENGES – FUTURE DIRECTIONS   
    At global level, the respect for patient values, preferences, and goals varies 
according to country-specific, or region-specific balance between paternalism and 
patient-centricity. Cultural, religious, legal, and socioeconomic barriers would have to 
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be overcome to apply harmonized policies supporting resource-demanding 
approaches (eg, POLST [31,32]) so as to effectively safeguard patient autonomy.  
    Examples from regions such as Oregon, United States [31,32] suggest that 
provision of information to the public in an "unbiased manner", preferably through 
organized and "free-of-charge" education on the benefits and limitations of 
resuscitation as well as knowledge of illness prognosis at individual level, may help 
patients (and their families) articulate their wishes. Patients and their loved ones 
should also be clearly aware of their rights emanating from the key ethical principles, 
as well as of the extent of these rights. Such actions and initiatives could benefit the 
society in general and vulnerable groups (eg, persons with poor socioeconomic status, 
and new immigrants/refugees) in particular. 
   Currently active caregivers should receive ethical practice training followed by 
predefined, skill-level certification so as to integrate the respect for autonomy and the 
other ethical principles in their daily practice. This would likely promote convergence 
to a more uniform interpretation of key principles amongst physicians and nurses and 
facilitate the application of currently recommended, structured, shared decision-
making procedures [9,10] in a preferably standardized manner. In addition, teaching 
of Medical Ethics at the pre-graduate level would equip the forthcoming generations 
of physicians and healthcare professionals with adequate theoretical knowledge 
(including clear definitions) of the key principles and of how they should be applied; 
this should be followed by ethical practice training and pertinent certification.   
     Ethical practices’ terminology should be harmonized to improve communication 
among involved parties and prevent confusion. For instance, consensus should be 
reached about the most suitable of acronyms denoting withholding of resuscitative 
interventions such as DNACPR, or DNAR (do-not-attempt resuscitation), or DNR 
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(do-not resuscitate). In addition, potential conceptual differences between withholding 
and withdrawing of LST should ideally be clearly defined based on the broadest 
possible consensus. Some ethicists regard LST withdrawal as active causation of 
death; in contrast, LST withholding means "passively allowing the patient to die" 
[73]. However, consequentialists see no ethically relevant distinction, because the 
end-result of these practices is essentially the same [73]. Regarding palliative sedo-
analgesia, current European guidelines are fairly explicit about indications and 
intensity of treatment (see above). 
     Addressing the issue of limited resources constitutes a major challenge in both 
developing and developed countries. Indeed, at global level, the equitable access to 
best possible emergency care [5] including expensive technological advancements 
such as extracorporeal CPR [65] seems like a theoretical ideal rather than a possible, 
near-future achievement. In sharp contrast, the widespread use of simple and 
beneficial interventions such as bystander CPR could be substantially augmented 
through organized, international education on resuscitation, preferably supported by 
the World Health Organization (WHO) and international Resuscitation Councils. 
WHO has already issued guidelines and launched initiatives to promote basic 
resuscitation of neonates in developing countries, thus improving accessibility to 
emergency care and potentially reducing subsequent morbidity/disability and/or 
mortality in this vulnerable population subgroup.     
    Regarding research, transparency could be promoted through data-sharing policies 
[74], and governmental funding of resuscitation research could be increased to 
become proportionate to cardiac arrest mortality burden [72]. Furthermore, the ethical 
credibility of partnerships between private and public sectors should be augmented by 
striking a balance between commercial interests and goals of investigators to promote 
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science [75]. Lastly, patients/families might actively contribute to the development of 
research objectives and ethical/clinical practice guidelines. 
CONCLUSION 
    Major challenges regarding the ethics of the rapidly advancing resuscitation science 
need to be addressed through widespread, coordinated, and sometimes resource-
demanding interventions. The physical, ethical and wider societal impacts of such 
actions need to be supported by ongoing and future research. 
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